Cargando…

Aβ Clearance, “hub” of Multiple Deficiencies Leading to Alzheimer Disease

Detalles Bibliográficos
Autores principales:	Gallina, Pasquale, Scollato, Antonio, Conti, Renato, Di Lorenzo, Nicola, Porfirio, Berardino
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2015
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4611243/ https://www.ncbi.nlm.nih.gov/pubmed/26539110 http://dx.doi.org/10.3389/fnagi.2015.00200

Ejemplares similares

Case report: A multiple sclerosis patient with imaging features of glymphatic failure benefitted from CSF flow shunting
por: Scollato, Antonio, et al.
Publicado: (2022)

Aqueductal CSF stroke volume measurements may drive management of shunted idiopathic normal pressure hydrocephalus patients
por: Scollato, Antonio, et al.
Publicado: (2021)

A commentary on “Differentiation of pluripotent stem cells into striatal projection neurons: a pure MSN fate may not be sufficient”
por: Porfirio, Berardino, et al.
Publicado: (2015)

The “Glymphatic-Lymphatic System Pathology” and a New Categorization of Neurodegenerative Disorders
por: Gallina, Pasquale, et al.
Publicado: (2021)

Large-sized Fetal Striatal Grafts in Huntington’s Disease Do Stop Growing: Long-term Monitoring in the Florence Experience
por: Mascalchi, Mario, et al.
Publicado: (2014)

Clearance of amyloid β-protein and its role in the spreading of Alzheimer's disease pathology
por: Thal, Dietmar R.
Publicado: (2015)

Editorial: Clearance Pathways for Amyloid-β. Significance for Alzheimer's Disease and Its Therapy
por: Carare, Roxana O.
Publicado: (2017)

Interaction between therapeutic interventions for Alzheimer’s disease and physiological Aβ clearance mechanisms
por: Morrone, Christopher D., et al.
Publicado: (2015)

Impaired Aβ clearance: a potential link between atherosclerosis and Alzheimer’s disease
por: Gupta, Ajay, et al.
Publicado: (2015)

In vivo Differential Brain Clearance and Catabolism of Monomeric and Oligomeric Alzheimer's Aβ protein
por: McIntee, Farron L., et al.
Publicado: (2016)

The low-density lipoprotein receptor-related protein 1 and amyloid-β clearance in Alzheimer’s disease
por: Kanekiyo, Takahisa, et al.
Publicado: (2014)

Editorial on, “Amyloid-beta clearance in Alzheimer's disease”
por: Marr, Robert A.
Publicado: (2014)

ROCK1 Is Associated with Alzheimer’s Disease-Specific Plaques, as well as Enhances Autophagosome Formation But not Autophagic Aβ Clearance
por: Hu, Yong-Bo, et al.
Publicado: (2016)

Neprilysin and Aβ Clearance: Impact of the APP Intracellular Domain in NEP Regulation and Implications in Alzheimer’s Disease
por: Grimm, Marcus O. W., et al.
Publicado: (2013)

Integrated analysis and identification of hub genes as novel biomarkers for Alzheimer’s disease
por: Zhao, Kun, et al.
Publicado: (2022)

Tau Clearance Mechanisms and Their Possible Role in the Pathogenesis of Alzheimer Disease
por: Chesser, Adrianne S., et al.
Publicado: (2013)

Dihydroartemisinin Ameliorates Learning and Memory in Alzheimer’s Disease Through Promoting Autophagosome-Lysosome Fusion and Autolysosomal Degradation for Aβ Clearance
por: Zhao, Yueyang, et al.
Publicado: (2020)

Soluble amyloid-β oligomers as synaptotoxins leading to cognitive impairment in Alzheimer’s disease
por: Ferreira, Sergio T., et al.
Publicado: (2015)

Mechanisms of Aβ Clearance and Degradation by Glial Cells
por: Ries, Miriam, et al.
Publicado: (2016)

Identification ferroptosis-related hub genes and diagnostic model in Alzheimer’s disease
por: Zhao, Huabin, et al.
Publicado: (2023)

Identification of Immune Hub Genes Associated With Braak Stages in Alzheimer’s Disease and Their Correlation of Immune Infiltration
por: Qian, Xiao-hang, et al.
Publicado: (2022)

Amyloid-beta and Alzheimer’s disease: the role of neprilysin-2 in amyloid-beta clearance
por: Marr, Robert A., et al.
Publicado: (2014)

A Simulation Model of Periarterial Clearance of Amyloid-β from the Brain
por: Diem, Alexandra K., et al.
Publicado: (2016)

Six mitophagy-related hub genes as peripheral blood biomarkers of Alzheimer’s disease and their immune cell infiltration correlation
por: Zhao, Kun, et al.
Publicado: (2023)

Hub Genes, Diagnostic Model, and Predicted Drugs Related to Iron Metabolism in Alzheimer's Disease
por: Gu, Xuefeng, et al.
Publicado: (2022)

Evidence for impaired amyloid β clearance in Alzheimer's disease
por: Wildsmith, Kristin R, et al.
Publicado: (2013)

The Hub-and-Spoke Management of Glaucoma
por: Nuzzi, Raffaele, et al.
Publicado: (2020)

The Cerebrovascular Basement Membrane: Role in the Clearance of β-amyloid and Cerebral Amyloid Angiopathy
por: Morris, Alan W. J., et al.
Publicado: (2014)

Based on molecular structures: Amyloid-β generation, clearance, toxicity and therapeutic strategies
por: Yang, Hai, et al.
Publicado: (2022)

Inhibition of Astrocytic Glutamine Synthetase by Lead is Associated with a Slowed Clearance of Hydrogen Peroxide by the Glutathione System
por: Robinson, Stephen R., et al.
Publicado: (2015)

Aluminum-Induced Amyloidogenesis and Impairment in the Clearance of Amyloid Peptides from the Central Nervous System in Alzheimer’s Disease
por: Zhao, Yuhai, et al.
Publicado: (2014)

Human Nmnat1 Promotes Autophagic Clearance of Amyloid Plaques in a Drosophila Model of Alzheimer’s Disease
por: Zhu, Yi, et al.
Publicado: (2022)

Over-Expressed Pathogenic miRNAs in Alzheimer’s Disease (AD) and Prion Disease (PrD) Drive Deficits in TREM2-Mediated Aβ42 Peptide Clearance
por: Zhao, Yuhai, et al.
Publicado: (2016)

Tau: A Signaling Hub Protein
por: Mueller, Rebecca L., et al.
Publicado: (2021)

Cortical Hub for Flavor Sensation in Rodents
por: Samuelsen, Chad L., et al.
Publicado: (2021)

Impaired vascular-mediated clearance of brain amyloid beta in Alzheimer’s disease: the role, regulation and restoration of LRP1
por: Ramanathan, Anita, et al.
Publicado: (2015)

Choroid plexus dysfunction impairs beta-amyloid clearance in a triple transgenic mouse model of Alzheimer’s disease
por: González-Marrero, Ibrahim, et al.
Publicado: (2015)

Ergothioneine, a dietary antioxidant improves amyloid beta clearance in the neuroretina of a mouse model of Alzheimer’s disease
por: Wijesinghe, Printha, et al.
Publicado: (2023)

DNA polymerase β deficiency leads to neurodegeneration and exacerbates Alzheimer disease phenotypes
por: Sykora, Peter, et al.
Publicado: (2015)

Therapeutic Potential of Direct Clearance of the Amyloid-β in Alzheimer’s Disease
por: Kim, Dong Eun, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_297pm31khjp471hgs26sqkp3u0